Strengthening the Service Base through the Utilization of Claims Data and Collaboration with the Medical Community
First written in FY2017. 9 of 17 entries say "Advanced", first in FY2024-Q1. Latest entry: 2026-08-03.
1 other company's latest entry also says "Advanced".
- 2026-08-03AdvancedOther Disclosures
「We began offering “Mirawell,” a function-selectable health-support API that automatically distributes health and lifestyle information tailored to users’ sex, age and place of residence by combining the medical big data “REZULT,” covering approximately 10 million people, with generative AI.」
The utilization of medical big data developed from existing claims-data utilization and other initiatives into the launch of an automated health-information distribution service using generative AI. - FY2026AdvancedAnnual report
「The main factors were higher revenue from data-utilization services, claims-review services and cloud-based claims-management services for public assistance, as well as improved profitability at K-Ship, which joined the business from the previous fiscal year.」
Increased revenue from high-value-added services such as data utilization services and improved profitability at ケーシップ confirmed the strengthening of the earnings base for healthcare DX and data utilization over the full fiscal year. - FY2026-H1AdvancedAnnual report
「The main factors were revenue growth in the claims review service, data utilization service, and cloud-based claims management service for public assistance, among others, as well as improved profitability at 株式会社ケーシップ, which joined this business in the previous fiscal year.」
High-value-added services, including data utilization services, increased in revenue, confirming the strengthening of the earnings base of the Medical Big Data Business in the interim results. - FY2025RaisedAnnual report
「Next, in the Medical Big Data Business, the Company will expand its earnings base by enhancing one-stop services for insurers built around J MICS, an automated medical claims inspection system, and iBss, an insurer operations support system, as well as by developing new business models for data utilization services and strengthening consulting services provided by a group of specialists. It will also promote comprehensive healthcare DX services by generating seeds through collaboration with academia and entering and expanding in new markets through M&A and alliances.」
The scope of initiatives expanded from the use of medical claims data and collaboration with academia to one-stop services, new data utilization models, specialist consulting, and entry into new markets through M&A and alliances. - FY2024-Q3AdvancedAnnual report
「The main factor was increased revenue from high-margin businesses such as analytical services and data utilization services.」
Data utilization services related to the use of medical claims data and other data increased in revenue along with analytical services, resulting in a 31.4% increase in Medical Big Data Business revenue and a 66.7% increase in operating profit. - FY2024-Q2AdvancedAnnual report
「The main factor was increased revenue from high-margin businesses such as analytical services and data utilization services.」
High-margin businesses such as analytical services and data utilization services increased in revenue, confirming the strengthening of the earnings base of the Medical Big Data Business in the reported results. - FY2024-Q1AdvancedAnnual report
「The main factor was increased revenue from high-margin businesses such as analytical services and data utilization services.」
Data utilization services related to the use of medical claims data and other data increased in revenue along with analytical services, and operating profit in the Medical Big Data Business rose 52.0% year on year. - FY2023RaisedAnnual report
「Next, in the Medical Big Data Business, the Company aims to increase earnings through a higher share of inspection services by automating the medical claims inspection process and developing new insurer markets, as well as through higher-value-added businesses such as strengthening specialist expertise by actively hiring qualified personnel and providing consulting services. It also aims to become a leading provider of insurer DX by expanding into new fields such as healthcare cost optimization and data health, generating seeds through collaboration with academia, strengthening its medical claims data utilization business through the development of advanced products, and expanding its business model.」
In addition to the existing use of medical claims data and collaboration with academia, the Company expanded its goals to include developing the insurer market, hiring qualified personnel, creating higher-value-added businesses and becoming a leading provider of insurer DX. - FY2022ReframedAnnual report
「The Company will evolve into a healthcare DX services provider by expanding its business model, including strengthening its medical claims data utilization business through expansion into new fields such as healthcare cost optimization and data health, generating seeds through collaboration with academia, and developing advanced products.」
The Company described its evolution into a healthcare DX services provider, based on improved medical claims inspection performance, data utilization, industry-government-academia collaboration and commercialization, with new fields such as healthcare cost optimization and data health included. - FY2021RaisedAnnual report
「The Company aims to increase earnings through a higher share of inspection services by automating medical claims processing and developing new insurer markets, as well as through higher-value-added businesses such as strengthening specialist expertise by actively hiring qualified personnel and providing consulting services. It will also strengthen its medical claims data utilization business by expanding into new fields such as healthcare cost optimization and data health, generating seeds through collaboration with academia, and developing advanced products, with the aim of becoming a leading vendor in this field.」
In addition to the existing initiatives of improving inspection performance, using medical claims data, industry-government-academia collaboration and commercialization, the scope of initiatives and targets expanded to include developing new insurer markets, hiring qualified personnel, providing consulting services, creating higher-value-added businesses and becoming a leading vendor. - FY2020RestatedAnnual report
「In the Medical Big Data Business, the Company will continue to automate inspections by the inspection engine and improve inspection performance, while expanding its product and solution lineup through the expansion of its medical claims data utilization business, joint research through industry-government-academia collaboration, and the research, development and commercialization of new technologies and businesses, thereby stabilizing its service business and strengthening its earnings base.」
The policy of strengthening the service platform through improved inspection performance, use of medical claims data, industry-government-academia collaboration, research and development, and commercialization continues. - FY2019RaisedAnnual report
「While continuing to automate inspections by the inspection engine and improve inspection performance, the Company will expand its services by realizing a business that makes use of medical claims data, conducting joint research through industry-government-academia collaboration using medical big data, and researching, developing and commercializing new technologies and businesses, thereby stabilizing its service business and strengthening its earnings base.」
The scope of initiatives has expanded from the use of medical claims data and collaboration with the medical community to joint research through industry-government-academia collaboration, and the research, development and commercialization of new technologies and businesses. - FY2017First statedAnnual report
「While continuing to automate inspections by the inspection engine and improve inspection performance, the Company will expand its services by realizing a business that makes use of medical claims data and collaborating with academia, thereby stabilizing its service business and strengthening its earnings base.」
In addition to improving existing inspection performance, the Company outlined plans to stabilize services and strengthen the earnings base through the use of medical claims data and collaboration with the medical community.